
LAS VEGAS — Cannabinoids have been shown to effectively control seizures across the epilepsy spectrum; however, quality control of products remains a challenge, according to a presenter at BRAINWeek 2022.
“We’re not really helped by the medical establishment, or government, or anybody else,” Jay Salpekar, MD, associate professor of psychiatry and neurology at Johns Hopkins University School of Medicine and director of neuropsychiatry in the epilepsy program at Kennedy Krieger Institute, said during the presentation. “That’s the thing that rang true with